Lorenzo Falchi
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, CAR-T cell therapy research, CNS Lymphoma Diagnosis and Treatment, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups(2020)192 cited
- → Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma(2021)186 cited
- → Combined oral 5-azacytidine and romidepsin are highly effective in patients with PTCL: a multicenter phase 2 study(2020)177 cited
- → Bispecific antibodies for the treatment of B-cell lymphoma: promises, unknowns, and opportunities(2022)172 cited
- → Correlation between FDG/PET, histology, characteristics, and survival in 332 patients with chronic lymphoid leukemia(2014)146 cited
- → A phase 1 study of romidepsin and pralatrexate reveals marked activity in relapsed and refractory T-cell lymphoma(2017)133 cited
- → Oral 5-azacytidine and romidepsin exhibit marked activity in patients with PTCL: a multicenter phase 1 study(2019)127 cited
- → Outcomes in patients with DLBCL treated with commercial CAR T cells compared with alternate therapies(2020)115 cited
- → Brentuximab vedotin plus bendamustine in relapsed or refractory Hodgkin's lymphoma: an international, multicentre, single-arm, phase 1–2 trial(2017)113 cited
- → Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy(2024)109 cited